Recently, Qiao Zhang, deputy mayor of Suzhou Government, deputy chairman of Jiangsu Committee of Chinese Peasants’ and Workers’ Democratic Party，chairman of Suzhou Committee of Chinese Peasants’ and Workers’ Democratic Party, made a field investigation of RainMed. He had a discussion on the independent innovation of domestic medical devices with Yunfei Huo, chairman of the board of directors, executive director and CEO of RainMed Medical. Kangjian Liu, vice president and secretary of the board of directors of RainMed, introduced RainMed's development strategy and core products. Yang Gu, vice president of RainMed and Chang Zhou accompanied them during the investigation. Hong Sun, deputy director of Suzhou Bureau of Industry and Information Technology; Jianhong Zhang, secondary researcher and full-time deputy chairwoman of Suzhou Committee of Chinese Peasants’ and Workers’ Democratic Party; Hongmei Lin, deputy minister of Suzhou Industrial Park Publicity and United Front Work Department and director of the Municipal Bureau of Ethnic and Religious Affairs participated in the investigation and exchange activity.

Deputy mayor Qiao Zhang visited the company accompanied by Mr. Yunfei Huo

During the visit, deputy mayor Qiao Zhang asked about RainMed’s founding intention and strategic planning, and learned about the clinical application and commercial progress of RainMed's self-developed products in detail. He affirmed the clinical value and innovation level of RainMed's products, and praised its strong sense of social responsibility. In the early stage of the epidemic, RainMed Medical gave full play to industrial advantages, actively participated in anti-epidemic in Suzhou and made contributions. Vice Mayor Qiao Zhang extended his sincere thanks to RainMed. Mr. Yunfei Huo also expressed his heartfelt thanks to Vice Mayor Qiao Zhang for his deep concern for the development of RainMed Medical. He said that Suzhou government attaches great importance to the development of bio-pharmaceutical enterprises and has issued a series of measures to benefit them. Since its establishment in Suzhou, RainMed Medical has received so much help and support from the government that it has kept developing rapidly and made great achievements. Therefore, it is also RainMed’s responsibility and obligation to establish a united front with Suzhou government to help Suzhou overcome the difficulties during the epidemic.

Mr. Kangjian Liu introduced RainMed's cardiovascular functional diagnostic products to Mr. Qiao Zhang

During the visit, Mr. Kangjian Liu, Vice President and Secretary to the Board of Directors, introduced RainMed’s vision and mission of "Targeted Medical Services for People's Health". RainMed adheres to independent research and development and is committed to overcoming clinical difficulties through scientific and technological innovation. Until 2022, it has successively launched FFR product with the highest accuracy in China-caFFR system, the world's first non-invasive IMR measurement product-caIMR system and FlashBot, the world's first vascular interventional surgery robot covering the whole process of diagnosis and treatment. In addition, RainMed has promoted its products to cover more than 1,000 hospitals in 30 provinces and autonomous regions in China, as well as 9 overseas countries and regions, making cutting-edge diagnosis and treatment products benefit vascular disease patients worldwide. Mr. Qiao Zhang and relevant leaders spoke highly of RainMed's strategic goal of developing vascular interventional surgical robots. He said that he would fully support the independent innovation of medical devices and encourage RainMed Medical to make continuous efforts to build a surgical robot innovation highland in Suzhou.